InUtero Gene Therapy: Progress and Challenges.
Trends in molecular medicine, 27(8): 728-730 PMID 34176774 DOI 10.1016/j.molmed.2021.05.007
Аннотация
In utero gene therapy has the potential to treat lethal and morbid perinatal diseases before birth. Small fetal size, a tolerogenic immune system, and dosing efficiency make the fetus a compelling patient. Numerous clinical, social, and institutional factors must be considered to achieve the promise of genetic treatment before birth.